Works from 2023
Pembrolizumab for patients with non-Hodgkin lymphoma: Phase 1b KEYNOTE-013 study, John Kuruvilla, Philippe Armand, Mehdi Hamadani, et al. (Article)
Rates of influenza and pneumococcal vaccination and correlation with survival in multiple myeloma patients, Michael A. Thompson, Mario Boccadoro, Xavier Leleu, et al. (Article)
Works from 2022
Bleeding Time, Andrew P. Russeau, Hacen Vall, and Biagio Manna (Book Chapter)
Cost-effectiveness of diagnostic strategies for venous thromboembolism: a systematic review, Yuan Zhang, Housne A. Begum, Himmat Grewal, et al. (Article)
Demand-only patient-controlled analgesia for treatment of acute vaso-occlusive pain in sickle cell disease, Veronica Carullo, Kerry Morrone, Meagan Weiss, et al. (Article)
Global treatment standard in multiple myeloma remains elusive: Updated results from the INSIGHT MM global, prospective, observational study, Noemi Puig, Vania TM Hungria, Ajai Chari, et al. (Abstract)
IGH/BCL2 status better predicts clinico-pathological behavior in primary splenic follicular lymphoma than histological grade and other molecular markers, Cherian Verghese, Weihong Li, Nanuli Gvazava, et al. (Article)
Impact of COVID-19 vaccines on INR, Ashley Green and Jennifer Martinez (Oral/Podium Presentation)
In reply: Costa et al, Jordan Spurling, Nicole Glowacki, and Marc McDowell (Response or Comment)
Long-term outcomes for ibrutinib-rituximab and chemoimmunotherapy in CLL: Updated results of the E1912 trial, Tait D. Shanafelt, Xin Victoria Wang, Curtis A. Hanson, et al. (Article)
Recurrent venous thromboembolism in a patient with nephrotic syndrome on rivaroxaban therapy, Dorota Magdon and Magdalena Flejsierowicz (Poster)
Split dose ATG strategy prevents grade III-IV acute GVHD and is associated with immune surrogates of GVL, Zaid Al-Kadhimi, Samuel Pirruccello, Zartash Gul, et al. (Letter)
There is no place like blina at home, Kristine Hoelle and Jessica Panice (Poster)
Vitamin B12 deficiency as unexpected cause of hemolytic anemia and atypical presentation of hepatocellular adenoma, Andrew Gregory and Magdalena Flejsierowicz (Poster)
Works from 2021
Comparison of high- and low-dose 4-factor prothrombin complex concentrate for the emergent reversal of oral Factor Xa inhibitors, Mary Hormese, Alex Littler, Brian Doane, et al. (Article)
Effects of Therapeutic Anticoagulation for SARS-CoV-2 Coagulopathy on Markers of Inflammation and Mortality, Lyndsey Turbow, Nancy Guirguis, Praveena Tathineni, Dana Mueller, Tyler Cooper, Daniel Thompson, Nicholas Goodmanson, John Weissert, Kouroush Ravvaz, and Kenneth W Dodd (Abstract)
Impact of plasma volume status on mortality following left ventricular assist device implantation, Teruhiko Imamura, Nikhil Narang, Pamela Combs, et al. (Article)
Reduced blood product utilization via implementation of an anemia clinic and consult service in a large health system hospital, Reid Christian Bowers, Sandra Tomany Korman, Michael A. Thompson, et al. (Abstract)
Thrombocytopenia in a 7-day-old male, Lindy Zhang, Caroline DeBoer, Alejandra Ellison-Barnes, et al. (Article)
Works from 2020
Caplacizumab for treatment of thrombotic thrombocytopenic purpura in a patient with anaphylaxis to fresh-frozen plasma, Mehraboon S. Irani, Federico Sanchez, and Kenneth Friedman (Article)
Clostridium paraputrificum: An atypical and rare case of septic arthritis mimicking an acute sickle cell crisis, Jordan Ciuro, Tania Little, Evan Hiner, et al. (Article)
Diagnosis of deep vein thrombosis of the lower extremity: a systematic review and meta-analysis of test accuracy, Meha Bhatt, Cody Braun, Payal Patel, et al. (Article)
Diagnosis of deep vein thrombosis of the upper extremity: A systematic review and meta-analysis of test accuracy, Payal Patel, Cody Braun, Parth Patel, et al. (Article)
Factors associated with deep venous thrombosis in patients infected with coronavirus disease 2019: A meta-analysis, Rohit S. Loomba, Gaurav Aggarwal, Enrique G Villarreal, et al. (Article)
Has the time come to implement gene therapy for sickle cell disease?, Norman Ginsberg and Lee P Shulman (Article)
Protocolized use of Factor Eight Inhibitor Bypassing Activity (FEIBA) for the reversal of warfarin induced coagulopathy, Natalie N Htet, David Barounis, Catherine Knight, et al. (Article)
Reduced blood product utilization via implementation of an anemia clinic and consult service in a large health system hospital, Reid Christian Bowers, Michael A. Thompson, Sandra Tomany Korman, et al. (Abstract)
Systematic review and meta-analysis of outcomes in patients with suspected deep vein thrombosis, Payal Patel, Parth Patel, Meha Bhatt, et al. (Article)
Systematic review and meta-analysis of test accuracy for the diagnosis of suspected pulmonary embolism, Parth Patel, Payal Patel, Meha Bhatt, et al. (Article)
Transplant referral patterns for patients (pts) with newly diagnosed (ND) higher-risk (HR) myelodysplastic dyndromes (MDS), and European leukemianet (ELN) 2010 intermediate-tisk (IR) or adverse-risk (AR) acute myeloid leukemia (AML) in the Connect® MDS/AML registry, Benjamin Tomlinson, Marcos de Lima, Christopher R. Cogle, et al. (Abstract)
Works from 2019
Anticoagulation RNs will demonstrate competence and consistency in practice, Adrianne Waters-Fechter (Poster)
Ibrutinib and rituximab provides superior clinical outcome compared to FCR in younger patients with chronic lymphocytic leukemia (CLL): Extended follow-up from the E1912 trial, Tait D Shanafelt, Victoria Wang, Neil E Kay, et al. (Article)
Ibrutinib-rituximab or chemoimmunotherapy for chronic lymphocytic leukemia, Tait D Shanafelt, Xin V Wang, Neil E Kay, et al. (Article)
INSIGHT MM: a large, global, prospective, non-interventional, real-world study of patients with multiple myeloma, Caitlin Costello, Faith E Davies, Gordon Cook, et al. (Article)
Use of intravenous immunoglobulin G to treat spontaneous heparin-induced thrombocytopenia, Mehraboon Irani, Eric Siegal, Abhay Jella, et al. (Article)
Works from 2018
A global treatment standard in multiple myeloma (MM) remains elusive despite advances in care over 15 years: first results from INSIGHT MM, the largest global prospective, observational MM study, Caitlin L. Costello, Mario Boccadoro, Michael A. Thompson, et al. (Abstract)
American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy, Daniel M Witt, Robby Nieuwlaat, Nathan P Clark, et al. (Article)
Contemporary risk factors and outcomes of transfusion-associated circulatory overload, Nareg H Roubinian, Jeanne E Hendrickson, Darrell J Triulzi, et al. (Article)
Follicular dendritic cell sarcoma with indolent T-lymphoblastic proliferation is associated with paraneoplastic autoimmune multiorgan syndrome, Matthew Walters, Mark R Pittelkow, Robert P Hasserjian, et al. (Article)
Works from 2017
A report of cerebral malaria treated with automated red blood cell exchange, Waseem Q Anani, Gerald P. Smith, Mehraboon Irani, et al. (Article)
Multiple Myeloma Baseline Immunoglobulin G Level and Pneumococcal Vaccination Antibody Response, Michael A. Thompson, Martin K. Oaks, Maharaj Singh, Karen M. Michel, Michael P. Mullane, Husam S. Tarawneh, Angi Kraut, and Kayla J. Hamm (Brief Report)
Multiple Myeloma Vaccination Patterns in a Large Health System: A Pilot Study, Andinet Alemu, Maharaj Singh, Chris Blumberg, John O. Richards, Martin K. Oaks, and Michael A. Thompson (Original Research)
Red cell exchange to mitigate a delayed hemolytic transfusion reaction in a patient transfused with incompatible red blood cells, Mehraboon S Irani, Matthew S Karafin, and Luke Ernster (Case Report)
Works from 2016
Comparison of ε-aminocaproic acid and tranexamic acid in reducing post-operative transfusions in total hip arthroplasty, Jessica L. Churchill, Kathleen E. Puca, Elizabeth S. Meyer, et al. (Abstract)
En bloc Liver kidney transplantation using donor splenic artery as inflow to the kidney. Report of two cases, Vikraman Gunabushanam, Jacob Clendenon, Erika Aldag, et al. (Article)
Evaluation of Preoperative Anemia and Transfusion Requirements in Adult Liver Transplant Recipients, Parissa Moghimi, Erika Aldag, Rachel Pedersen, et al. (Poster)
Social media and internet resources for patients with blastic plasmacytoid dendritic cell neoplasm (bpdcn), Naveen Pemmaraju, Vikas Gupta, Michael A. Thompson, et al. (Article)
Social media and myeloproliferative neoplasms (mpn): analysis of advanced metrics from the first year of a new twitter community: #mpnsm, Naveen Pemmaraju, Audun Utengen, Vikas Gupta, et al. (Article)
Works from 2015
‘Everyone is an individual’: providing individualized treatment in oncology, Michael A. Thompson (Article)
Red cell exchange to mitigate a delayed hemolytic transfusion reaction in a patient transfused with incompatible red blood cells: 54, Mehraboon S. Irani, Luke Ernster, and Matthew Karafin (Abstract)
Social Media and the practicing hematologist: Twitter 101 for the busy healthcare provider, Michael A. Thompson, Navneet S Majhail, William A Wood, et al. (Article)
Works from 2012
Flow cytometry assessment of residual melanoma cells in tumor-infiltrating lymphocyte cultures, John O. Richards, Jonathan Treisman, Nina Garlie, et al. (Article)
Works from 2009
Biochemical analysis of CTLA-4 immunoreactive material from human blood, Matt Tector, Bhupendra O Khatri, Karen Kozinski, et al. (Article)
Works from 2008
Lack of association between sCTLA-4 levels in human plasma and common CTLA-4 polymorphisms, Andrew Berry, Matt Tector, and Martin Oaks (Article)